MD Anderson Research Highlights for November 21, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Modified drug reverses chronic pain with reduced side effects
Oxidative stress, which can cause...
MD Anderson receives nearly $8 million in CPRIT funding for screening and early detection programs, faculty recruitment
The University of Texas MD Anderson Cancer Center today was awarded nearly $8 million from the Cancer Prevention and Research Institute of...
Healthy women have cells that resemble breast cancer, study finds
A new study from researchers at The University of Texas MD Anderson Cancer Center finds that, in healthy women, some breast cells that otherwise...
MD Anderson Research Highlights: SITC 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
This special edition features upcoming oral presentations by MD Anderson researchers...
MD Anderson launches Institute for Cell Therapy Discovery & Innovation to deliver transformational new therapies
The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation,...
Jennifer Bickel, M.D., named MD Anderson Vice President and Chief Wellness Officer
The University of Texas MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution’s inaugural vice...
Quitting smoking after cancer diagnosis improves survival across a wide variety of cancers
Smokers who are diagnosed with cancer now have more incentive to quit, as researchers from The University of Texas MD Anderson Cancer Center...
MD Anderson Research Highlights for October 30, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
MD Anderson statement on BCBS TX ending Medicare Advantage and Medicaid plans
Blue Cross Blue Shield notified The University of Texas MD Anderson Cancer Center it will end its Letter of Agreement for Medicare Advantage...
Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed...